These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28067167)
41. ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease. Marques AT; Fernandes PA; Ramos MJ Mini Rev Med Chem; 2009 Jul; 9(8):1002-8. PubMed ID: 19601895 [TBL] [Abstract][Full Text] [Related]
42. In silico-designed novel non-peptidic ABAD L Viswanath ANI; Kim T; Jung SY; Lim SM; Pae AN Chem Biol Drug Des; 2017 Dec; 90(6):1041-1055. PubMed ID: 28660722 [TBL] [Abstract][Full Text] [Related]
43. Hydroxysteroid (17β) dehydrogenase X in human health and disease. Yang SY; He XY; Miller D Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223 [TBL] [Abstract][Full Text] [Related]
44. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Lustbader JW; Cirilli M; Lin C; Xu HW; Takuma K; Wang N; Caspersen C; Chen X; Pollak S; Chaney M; Trinchese F; Liu S; Gunn-Moore F; Lue LF; Walker DG; Kuppusamy P; Zewier ZL; Arancio O; Stern D; Yan SS; Wu H Science; 2004 Apr; 304(5669):448-52. PubMed ID: 15087549 [TBL] [Abstract][Full Text] [Related]
45. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase. Yang SY; He XY; Schulz H Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413 [TBL] [Abstract][Full Text] [Related]
46. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders. Benek O; Hroch L; Aitken L; Gunn-Moore F; Vinklarova L; Kuca K; Perez DI; Perez C; Martinez A; Fisar Z; Musilek K J Enzyme Inhib Med Chem; 2018 Dec; 33(1):665-670. PubMed ID: 29536773 [TBL] [Abstract][Full Text] [Related]
47. [Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease]. Benek O; Musílek K; Kuca K Ceska Slov Farm; 2012 Aug; 61(4):144-9. PubMed ID: 23251955 [TBL] [Abstract][Full Text] [Related]
48. Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase. He XY; Wegiel J; Yang SY Brain Res; 2005 Apr; 1040(1-2):29-35. PubMed ID: 15804423 [TBL] [Abstract][Full Text] [Related]
49. Friend or enemy? Review of 17β-HSD10 and its role in human health or disease. Vinklarova L; Schmidt M; Benek O; Kuca K; Gunn-Moore F; Musilek K J Neurochem; 2020 Nov; 155(3):231-249. PubMed ID: 32306391 [TBL] [Abstract][Full Text] [Related]
51. Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model. Yao J; Taylor M; Davey F; Ren Y; Aiton J; Coote P; Fang F; Chen JX; Yan SD; Gunn-Moore FJ Mol Cell Neurosci; 2007 Jun; 35(2):377-82. PubMed ID: 17490890 [TBL] [Abstract][Full Text] [Related]
52. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. Takuma K; Yao J; Huang J; Xu H; Chen X; Luddy J; Trillat AC; Stern DM; Arancio O; Yan SS FASEB J; 2005 Apr; 19(6):597-8. PubMed ID: 15665036 [TBL] [Abstract][Full Text] [Related]
53. Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase. He XY; Yang YZ; Peehl DM; Lauderdale A; Schulz H; Yang SY J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):191-8. PubMed ID: 14672739 [TBL] [Abstract][Full Text] [Related]
56. Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). Yan SD; Stern DM Int J Exp Pathol; 2005 Jun; 86(3):161-71. PubMed ID: 15910550 [TBL] [Abstract][Full Text] [Related]
57. Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics. Vangavaragu JR; Valasani KR; Fang D; Williams TD; Yan SS J Alzheimers Dis; 2014; 42(1):333-44. PubMed ID: 24858403 [TBL] [Abstract][Full Text] [Related]
58. Harnessing functional plasticity of enzymes: a fluorogenic probe for imaging 17beta-HSD10 dehydrogenase, an enzyme involved in Alzheimer's and Parkinson's diseases. Froemming MK; Sames D J Am Chem Soc; 2007 Nov; 129(46):14518-22. PubMed ID: 17958419 [TBL] [Abstract][Full Text] [Related]
59. Overexpression of 17β-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death. Carlson EA; Marquez RT; Du F; Wang Y; Xu L; Yan SS BMC Cancer; 2015 Mar; 15():166. PubMed ID: 25879199 [TBL] [Abstract][Full Text] [Related]
60. Undetectable levels of CSF amyloid-β peptide in a patient with 17β-hydroxysteroid dehydrogenase deficiency. Ortez C; Villar C; Fons C; Duarte ST; Pérez A; García-Villoria J; Ribes A; Ormazábal A; Casado M; Campistol J; Vilaseca MA; García-Cazorla A J Alzheimers Dis; 2011; 27(2):253-7. PubMed ID: 21841256 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]